Skip to content

National Survey of People With Haemophilia in Portugal

Sociodemographic, Clinic and Psychosocial Aspects of People With Haemophilia in Portugal: a National Survey

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02870114
Enrollment
146
Registered
2016-08-17
Start date
2016-09-30
Completion date
2017-05-22
Last updated
2017-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemophilia

Keywords

Haemophilia, Quality of Life, Distress, Hemarthrosis, Pain

Brief summary

The purpose of this study is to implement a national survey to collect information regarding Portuguese people with haemophilia (PWH) on socio-demographic, clinical and psychosocial factors.

Detailed description

This is a cross-sectional design investigation focused on the socio-demographic, clinical and psychosocial characterization of Portuguese people with haemophilia (PWH). All PWH, registered in the Portuguese Hemophilia Association (APH) will be identified in APH registries and contacted through mail, in order to be invited to participate in the first Portuguese survey on haemophilia. In case of acceptance, patients must sign the Informed Consent, fill in the questionnaires and send both back to the investigation team through a pre-paid envelope in the national mail system. PWH of all ages are invited to participate in this survey. Adults (aged 18 and over) and children/youth from 10 to 17 will answer the questionnaires by self report. Parents of small children (0 to 9) will fill in the proxy versions. All questionnaires are adapted for the specific age groups. This study will comply with ethic guidelines and was approved by the Life Sciences and Health Ethics Subcommittee (University of Minho) and is registered on the Portuguese authority for data collection (CNPD).

Interventions

None listed

Sponsors

Hospital Sao Joao
CollaboratorOTHER
Portuguese hemophilia association and other congenital coagulopathies
CollaboratorUNKNOWN
University of Minho
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Haemophilia A or B * Portuguese nationality

Exclusion criteria

* Acquired Haemophilia * Psychiatric or neurological deficit

Design outcomes

Primary

MeasureTime frameDescription
Health Related Quality of Life in Adults as assessed by A36Hemofilia-Qol1 year
Health Related Quality of Life in Children as assessed by Canadian Haemophilia Outcomes-Kids Life Assessment Tool1 yearHealth Related Quality of Life in Children
Pain Intensity1 yearPain Questionnaire developed specifically for this investigation to assess PWH (based on Wallny's Pain Questionnaire for PWH and Brief Pain Inventory).
Pain Location1 yearPain Questionnaire developed specifically for this investigation to assess PWH (based on Wallny's Pain Questionnaire for PWH and Brief Pain Inventory).
Pain Duration1 yearPain Questionnaire developed specifically for this investigation to assess PWH (based on Wallny's Pain Questionnaire for PWH and Brief Pain Inventory).

Secondary

MeasureTime frameDescription
Illness Perception as assessed by IPQ-R1 year
Pain Catastrophizing as assessed by CSQ - Catastrophizing Subscale1 year
Presence of inibitors1 year
Type of sports practiced by PWH1 year
Number of Joint Bleeds1 year
Number of target joints1 year
Total score of Haemophilia-related functional limitations as assessed by Haemophilia Activities List (HAL) and Pediatric HAL1 year
Anxiety score as assessed by PROMIS-Anxiety Short Form v1.01 weekAssessmet of Anxiety
Depression score as assessed by PROMIS-Depression Short Form v1.01 week

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026